Virtus LifeSci Biotech Products ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBP and other ETFs, options, and stocks.

About BBP

BBP tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. 

Index-Tracked
FT Wilshire 5000 TR USD
Index-TrackedFT Wilshire 5000 TR USD
Category
Health
CategoryHealth
Number of holdings
66
Number of holdings66
Inception Date
Dec 16, 2014
Inception DateDec 16, 2014

BBP Key Statistics

AUM
43.47M
AUM43.47M
Price-Earnings ratio
-32.12
Price-Earnings ratio-32.12
30-Day yield
30-Day yield
Average volume
2.96K
Average volume2.96K
High today
$81.83
High today$81.83
Low today
$80.92
Low today$80.92
Open price
$80.92
Open price$80.92
Volume
3.70K
Volume3.70K
52 Week high
$82.63
52 Week high$82.63
52 Week low
$48.65
52 Week low$48.65
Expense ratio
0.79
Expense ratio0.79

Stock Snapshot

Virtus LifeSci Biotech Products ETF(BBP) stock is priced at $81.72, giving the company a market capitalization of 44.95M. It carries a P/E multiple of -32.12 and pays a dividend yield of 9.4%.

During the trading session on 2026-01-07, Virtus LifeSci Biotech Products ETF(BBP) shares reached a daily high of $81.83 and a low of $80.92. At a current price of $81.72, the stock is +1.0% higher than the low and still -0.1% under the high.

Trading activity shows a volume of 3.7K, compared to an average daily volume of 2.96K.

The stock's 52-week range extends from a low of $48.65 to a high of $82.63.

The stock's 52-week range extends from a low of $48.65 to a high of $82.63.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.